# Annovis Bio, Inc.: Form 8-K, filed Jun 3, 2022

- Company: [Annovis Bio, Inc.](/companies/anvs.md) (CIK 1477845)
- Form: 8-K
- Filed: 2022-06-03
- Accepted by EDGAR: Jun 3, 2022, 08:54 ET
- Period: 2022-06-02
- Accession: 0001104659-22-067880
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1477845/000110465922067880/tm2217603d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1477845/000110465922067880/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1477845/000110465922067880/tm2217603d1_8k.htm

Filed Jun 3, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-067880. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
